Summary
The authors established a new experimental model of fulminant hepatic failure (FHF) with prolonged hepatocellular necrosis and impaired liver regeneration, and evaluated the immunological mechanisms related to the impaired liver regeneration in this model. A novel lipid A analogue, FS-112, was injected intravenously into male Balb/c mice, followed by a 70% partial hepatectomy 2 days later. Serum levels of T.Bil. and ALT rose 7 days after the partial hepatectomy, as compared with controls. In mice pretreated with FS-112, labeling indices of both BrdU and PCNA 36 hrs after the partial hepatectomy were significantly lower than those in the controls. Splenic lymphocytes harvested from the FHF mice 1–5 days after the partial hepatectomy showed a cytotoxic activity against regenerating hepatocytes with a peak effect on day 5. Cytotoxic activity against YAC-1 cells was also found up to 5 days after the partial hepatectomy, and resembled that directed against the regenerating hepatocytes. On the 5th day of FS-112 administration, there was a marked rise in the production of IFN-γ from splenocytes. When FK-506, an immunosuppressive agent, was given intracutaneously daily for 7 days, serum levels of T.Bil. and ALT significantly decreased, as compared with controls. Furthermore, the PCNA-labeling index 36 hrs after the partial hepatectomy was enhanced by the administration with FK-506 in the FHF mice. These results strongly suggest that the NK cells activated by IFN-y may be involved in killing the regenerating liver cells, and thus play a role in the pathogenesis of the impaired liver regeneration in FHF. Furthermore, it has been suggested that FK-506 may be beneficial for recovery from the impaired liver regeneration in FHF.
Similar content being viewed by others
References
Gratzner HG. Monoclonal antibody to 5-bromo- and 5′-iodode-oxyuridine: a new reagent for detection DNA replication. Science 1982;218:474–476.
Gerdes J, Lemke H, Baisch H, et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710–1715.
Masaki S, Shiku H, Kaneda T, et al. Production and characterization of monoclonal antibody against 10S DNA polymerase α from calf thymus. Nucleic Acids Res 1982;10:4703–4713.
Bravo R, Flank R, Blundell PA, et al. Cyclin/PCNA is the auxiliary protein of DNA polymerase-δ. Nature 1987;326:515–517.
Jonker AM, Dijkhuis FW, Kroese FGM, et al. Immunopathology of acute galactosamine hepatitis in rats. Hepatology 1990;11:622–627.
Paolucci F, Mancini R, Marucci L, et al. Immunohistochemical identification of proliferating cells following dimethylnitrosamineinduced liver injury. Liver 1990;10:278–281.
Higgins GM, Anderson RM. Experimental pathology of the liver: I. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931;12:186–202.
Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol 1976;13:29–83.
Ichihara A, Nakamura T, Tanaka K, et al. Biochemical studies on liver functions of adult rat hepatocytes in primary culture. Ann NY Acad Sci 1980;349:77–84.
Sjögren HO, Hellström I. Induction of polyoma specific transplantation antigenecity in Moloney leukemia cells. Exp Cell Res 1965;40:208–212.
Nakamura T, Nawa K, Ichihara A, et al. Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett 1987;224:311–316.
Gohda E, Tsubouchi H, Nakayama H, et al. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 1988;342:440–443.
Zarnegar R, Michalopoulos G. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes. Cancer Res 1989;49:3314–3320.
Tsubouchi H, Hirono S, Gohda E, et al. Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure. Hepatology 1989;9:875–881.
Author information
Authors and Affiliations
Additional information
This work was supported in part by grant (01-03-3) from the Research Group of Intractable Hepatitis sponsored by the Ministry of Health and Welfare of Japan, and by Grant-in-Aid for Co-operative Research (A) (01304038) from the Ministry of Education, Science and Culture of Japan.
Rights and permissions
About this article
Cite this article
Ohnishi, H., Muto, Y., Maeda, T. et al. Natural killer cell may impair liver regeneration in fulminant hepatic failure. Gastroenterol Jpn 28 (Suppl 4), 40–44 (1993). https://doi.org/10.1007/BF02782888
Issue Date:
DOI: https://doi.org/10.1007/BF02782888